OPPM
Opus Point Partners Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $654K | Buy |
9,700
+300
| +3% | +$20.2K | 1.18% | 18 |
|
|
2019
Q2 | $805K | Buy |
9,400
+301
| +3% | +$25.8K | 1.19% | 19 |
|
|
2019
Q1 | $808K | Sell |
9,099
-599
| -6% | -$53.2K | 1.1% | 19 |
|
|
2018
Q4 | $826K | Sell |
9,698
-156
| -2% | -$13.3K | 1.82% | 14 |
|
|
2018
Q3 | $956K | Sell |
9,854
-482
| -5% | -$46.8K | 2.28% | 19 |
|
|
2018
Q2 | $974K | Sell |
10,336
-320
| -3% | -$30.2K | 2.11% | 20 |
|
|
2018
Q1 | $864K | Sell |
10,656
-6,462
| -38% | -$524K | 1.69% | 19 |
|
|
2017
Q4 | $1.53M | Sell |
17,118
-2,808
| -14% | -$250K | 1.32% | 24 |
|
|
2017
Q3 | $1.86M | Buy |
19,926
+3,164
| +19% | +$295K | 1.66% | 25 |
|
|
2017
Q2 | $1.52M | Sell |
16,762
-16,149
| -49% | -$1.47M | 1.39% | 24 |
|
|
2017
Q1 | $2.89M | Buy |
32,911
+1,332
| +4% | +$117K | 2.14% | 23 |
|
|
2016
Q4 | $2.62M | Buy |
31,579
+940
| +3% | +$77.9K | 2.08% | 20 |
|
|
2016
Q3 | $2.84M | Buy |
30,639
+1,724
| +6% | +$160K | 1.59% | 21 |
|
|
2016
Q2 | $2.25M | Sell |
28,915
-19,345
| -40% | -$1.51M | 2.17% | 21 |
|
|
2016
Q1 | $3.98M | Buy |
48,260
+4,390
| +10% | +$362K | 3.08% | 6 |
|
|
2015
Q4 | $4.6M | Buy |
43,870
+1,858
| +4% | +$195K | 3.04% | 15 |
|
|
2015
Q3 | $4.43M | Buy |
42,012
+6,113
| +17% | +$644K | 2.44% | 13 |
|
|
2015
Q2 | $4.91M | Buy |
35,899
+3,354
| +10% | +$459K | 3.89% | 3 |
|
|
2015
Q1 | $4.06M | Sell |
32,545
-11,186
| -26% | -$1.39M | 3.4% | 4 |
|
|
2014
Q4 | $3.95M | Buy |
+43,731
| New | +$3.95M | 3.91% | 3 |
|